{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:58:57Z","timestamp":1785117537261,"version":"3.55.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2022YFC3602004"],"award-info":[{"award-number":["2022YFC3602004"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2025-I2M-KJ-012"],"award-info":[{"award-number":["2025-I2M-KJ-012"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270915"],"award-info":[{"award-number":["32270915"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U20A20374"],"award-info":[{"award-number":["U20A20374"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Prospective Research Program of Changzhou Xitaihu Development Foundation For Frontier Cell-Therapeutic Technology","award":["2024-P-013"],"award-info":[{"award-number":["2024-P-013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08234-7","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T06:45:06Z","timestamp":1778309106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["V\u03b41 T cells exhibit high lactic acid resistance and antitumor activity in solid tumors"],"prefix":"10.1186","volume":"24","author":[{"given":"Yiming","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghua","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"issue":"1","key":"8234_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41571-023-00832-4","volume":"21","author":"SM Albelda","year":"2024","unstructured":"Albelda SM. CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn. Nat reviews Clin Oncol. 2024;21(1):47\u201366.","journal-title":"Nat reviews Clin Oncol"},{"issue":"4","key":"8234_CR2","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.ccell.2025.03.019","volume":"43","author":"B Du","year":"2025","unstructured":"Du B, Qin J, Lin B, Zhang J, Li D, Liu M. CAR-T therapy in solid tumors. Cancer Cell. 2025;43(4):665\u201379.","journal-title":"Cancer Cell"},{"key":"8234_CR3","doi-asserted-by":"crossref","unstructured":"Ayala Ceja M, Khericha M, Harris CM, Puig-Saus C, Chen YY. CAR-T cell manufacturing: Major process parameters and next-generation strategies. J Exp Med. 2024;221(2).","DOI":"10.1084\/jem.20230903"},{"issue":"2","key":"8234_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","volume":"18","author":"JA Myers","year":"2021","unstructured":"Myers JA, Miller JS. Exploring the NK cell platform for cancer immunotherapy. Nat reviews Clin Oncol. 2021;18(2):85\u2013100.","journal-title":"Nat reviews Clin Oncol"},{"issue":"3","key":"8234_CR5","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41571-022-00722-1","volume":"20","author":"S Mensurado","year":"2023","unstructured":"Mensurado S, Blanco-Dom\u00ednguez R, Silva-Santos B. The emerging roles of \u03b3\u03b4 T cells in cancer immunotherapy. Nat reviews Clin Oncol. 2023;20(3):178\u201391.","journal-title":"Nat reviews Clin Oncol"},{"key":"8234_CR6","doi-asserted-by":"publisher","first-page":"573156","DOI":"10.3389\/fimmu.2020.573156","volume":"11","author":"R Fazzi","year":"2020","unstructured":"Fazzi R, Petrini I, Giuliani N, Morganti R, Carulli G, Dalla Palma B, et al. Phase II Trial of Maintenance Treatment With IL2 and Zoledronate in Multiple Myeloma After Bone Marrow Transplantation: Biological and Clinical Results. Front Immunol. 2020;11:573156.","journal-title":"Front Immunol"},{"key":"8234_CR7","doi-asserted-by":"publisher","first-page":"216730","DOI":"10.1016\/j.canlet.2024.216730","volume":"587","author":"C Cheng","year":"2024","unstructured":"Cheng C, Liang S, Yue K, Wu N, Li Z, Dong T, et al. STAT5 is essential for inducing the suppressive subset and attenuate cytotoxicity of V\u03b42(+) T cells in acute myeloid leukemia. Cancer Lett. 2024;587:216730.","journal-title":"Cancer Lett"},{"issue":"4","key":"8234_CR8","doi-asserted-by":"publisher","first-page":"e800","DOI":"10.1002\/ctm2.800","volume":"12","author":"W He","year":"2022","unstructured":"He W, Hu Y, Chen D, Li Y, Ye D, Zhao Q, et al. Hepatocellular carcinoma-infiltrating \u03b3\u03b4 T cells are functionally defected and allogenic V\u03b42(+) \u03b3\u03b4 T cell can be a promising complement. Clin translational Med. 2022;12(4):e800.","journal-title":"Clin translational Med"},{"key":"8234_CR9","doi-asserted-by":"crossref","unstructured":"Ebert LM, Meuter S, Moser B. Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance. J Immunol (Baltimore, Md: 1950). 2006;176(7):4331-6.","DOI":"10.4049\/jimmunol.176.7.4331"},{"key":"8234_CR10","doi-asserted-by":"publisher","first-page":"1286097","DOI":"10.3389\/fimmu.2023.1286097","volume":"14","author":"J Schadeck","year":"2023","unstructured":"Schadeck J, Oberg HH, Peipp M, Hedemann N, Schamel WW, Bauerschlag D, et al. Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3. Front Immunol. 2023;14:1286097.","journal-title":"Front Immunol"},{"issue":"1","key":"8234_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2162-3619-2-14","volume":"2","author":"I Prinz","year":"2013","unstructured":"Prinz I, Thamm K, Port M, Weissinger EM, Stadler M, Gabaev I, et al. Donor V\u03b41\u2009+\u2009\u03b3\u03b4 T cells expand after allogeneic hematopoietic stem cell transplantation and show reactivity against CMV-infected cells but not against progressing B-CLL. Experimental Hematol Oncol. 2013;2(1):14.","journal-title":"Experimental Hematol Oncol"},{"issue":"6","key":"8234_CR12","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s43018-022-00376-z","volume":"3","author":"Y Wu","year":"2022","unstructured":"Wu Y, Biswas D, Usaite I, Angelova M, Boeing S, Karasaki T, et al. A local human V\u03b41 T cell population is associated with survival in nonsmall-cell lung cancer. Nat cancer. 2022;3(6):696\u2013709.","journal-title":"Nat cancer"},{"key":"8234_CR13","doi-asserted-by":"publisher","first-page":"14760","DOI":"10.1038\/ncomms14760","volume":"8","author":"MS Davey","year":"2017","unstructured":"Davey MS, Willcox CR, Joyce SP, Ladell K, Kasatskaya SA, McLaren JE, et al. Clonal selection in the human V\u03b41 T cell repertoire indicates \u03b3\u03b4 TCR-dependent adaptive immune surveillance. Nat Commun. 2017;8:14760.","journal-title":"Nat Commun"},{"issue":"1","key":"8234_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cellimm.2015.04.008","volume":"296","author":"EJ Adams","year":"2015","unstructured":"Adams EJ, Gu S, Luoma AM. Human gamma delta T cells: Evolution and ligand recognition. Cell Immunol. 2015;296(1):31\u201340.","journal-title":"Cell Immunol"},{"issue":"12","key":"8234_CR15","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1182\/blood.V96.12.3827","volume":"96","author":"RD Lopez","year":"2000","unstructured":"Lopez RD, Xu S, Guo B, Negrin RS, Waller EK. CD2-mediated IL-12-dependent signals render human gamma delta-T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: implications for the development of adoptive immunotherapy strategies. Blood. 2000;96(12):3827\u201337.","journal-title":"Blood"},{"issue":"23","key":"8234_CR16","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1158\/1078-0432.CCR-16-0597","volume":"22","author":"AR Almeida","year":"2016","unstructured":"Almeida AR, Correia DV, Fernandes-Platzgummer A, da Silva CL, da Silva MG, Anjos DR, et al. Delta One T Cells for Immunotherapy of Chronic Lymphocytic Leukemia: Clinical-Grade Expansion\/Differentiation and Preclinical Proof of Concept. Clin cancer research: official J Am Association Cancer Res. 2016;22(23):5795\u2013804.","journal-title":"Clin cancer research: official J Am Association Cancer Res"},{"issue":"2","key":"8234_CR17","doi-asserted-by":"publisher","first-page":"e1373","DOI":"10.1002\/cti2.1373","volume":"11","author":"KP Nishimoto","year":"2022","unstructured":"Nishimoto KP, Barca T, Azameera A, Makkouk A, Romero JM, Bai L, et al. Allogeneic CD20-targeted \u03b3\u03b4 T cells exhibit innate and adaptive antitumor activities in preclinical B-cell lymphoma models. Clin translational Immunol. 2022;11(2):e1373.","journal-title":"Clin translational Immunol"},{"key":"8234_CR18","doi-asserted-by":"crossref","unstructured":"Makkouk A, Yang XC, Barca T, Lucas A, Turkoz M, Wong JTS, et al. Off-the-shelf V\u03b41 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma. J Immunother Cancer. 2021;9(12).","DOI":"10.1136\/jitc-2021-003441"},{"key":"8234_CR19","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez Mart\u00ednez D, Tirado N, Mensurado S, Mart\u00ednez-Moreno A, Romec\u00edn P, Guti\u00e9rrez Ag\u00fcera F et al. Generation and proof-of-concept for allogeneic CD123 CAR-Delta One T (DOT) cells in acute myeloid leukemia. J Immunother Cancer. 2022;10(9).","DOI":"10.1136\/jitc-2022-005400"},{"issue":"23","key":"8234_CR20","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1158\/0008-5472.CAN-24-0195","volume":"84","author":"L Jiang","year":"2024","unstructured":"Jiang L, You F, Wu H, Qi C, Xiang S, Zhang P, et al. B7-H3-Targeted CAR-V\u03b41T Cells Exhibit Potent Broad-Spectrum Activity against Solid Tumors. Cancer Res. 2024;84(23):4066\u201380.","journal-title":"Cancer Res"},{"key":"8234_CR21","doi-asserted-by":"crossref","unstructured":"Li Z, Liu N, Shah Z, Jin L, Tian L, Sun X et al. Comparative efficacy and safety of PSCA CAR-engineered V\u03b41 \u03b3\u03b4 T cells for immunotherapy of pancreatic cancer. J Immunother Cancer. 2025;13(9).","DOI":"10.1136\/jitc-2025-011890"},{"key":"8234_CR22","doi-asserted-by":"crossref","unstructured":"Zhu G, Sun Z, Liu Y, Liu J, Guo L, Pei G, et al. Rational design and organoid-based evaluation of a cocktail CAR-\u03b3\u03b4 T Cell therapy for heterogeneous glioblastoma. Adv Sci (Weinheim, Baden-Wurttemberg, Germany). 2025;12(19):e2501772.","DOI":"10.1002\/advs.202501772"},{"key":"8234_CR23","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1126\/scitranslmed.aax9364","volume":"11","author":"Y Wu","year":"2019","unstructured":"Wu Y, Kyle-Cezar F, Woolf RT, Naceur-Lombardelli C, Owen J, Biswas D, et al. An innate-like V\u03b41(+) \u03b3\u03b4 T cell compartment in the human breast is associated with remission in triple-negative breast cancer. Sci Transl Med. 2019;11:513.","journal-title":"Sci Transl Med"},{"issue":"10","key":"8234_CR24","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrm.2017.53","volume":"18","author":"A Ray Chaudhuri","year":"2017","unstructured":"Ray Chaudhuri A, Nussenzweig A. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nat Rev Mol Cell Biol. 2017;18(10):610\u201321.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8047","key":"8234_CR25","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41586-024-08261-8","volume":"637","author":"D Steffin","year":"2025","unstructured":"Steffin D, Ghatwai N, Montalbano A, Rathi P, Courtney AN, Arnett AB, et al. Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers. Nature. 2025;637(8047):940\u20136.","journal-title":"Nature"},{"issue":"24","key":"8234_CR26","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1158\/0008-5472.CAN-15-1498","volume":"75","author":"K Pilipow","year":"2015","unstructured":"Pilipow K, Roberto A, Roederer M, Waldmann TA, Mavilio D, Lugli E. IL15 and T-cell Stemness in T-cell-Based Cancer Immunotherapy. Cancer Res. 2015;75(24):5187\u201393.","journal-title":"Cancer Res"},{"issue":"9","key":"8234_CR27","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/cas.13005","volume":"107","author":"Y Kimura","year":"2016","unstructured":"Kimura Y, Nagai N, Tsunekawa N, Sato-Matsushita M, Yoshimoto T, Cua DJ, et al. IL-17A-producing CD30(+) V\u03b41 T cells drive inflammation-induced cancer progression. Cancer Sci. 2016;107(9):1206\u201314.","journal-title":"Cancer Sci"},{"issue":"5","key":"8234_CR28","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","volume":"176","author":"C Jin","year":"2019","unstructured":"Jin C, Lagoudas GK, Zhao C, Bullman S, Bhutkar A, Hu B, et al. Commensal Microbiota Promote Lung Cancer Development via \u03b3\u03b4 T Cells. Cell. 2019;176(5):998\u2013e101316.","journal-title":"Cell"},{"issue":"5","key":"8234_CR29","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.immuni.2014.03.013","volume":"40","author":"P Wu","year":"2014","unstructured":"Wu P, Wu D, Ni C, Ye J, Chen W, Hu G, et al. \u03b3\u03b4T17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity. 2014;40(5):785\u2013800.","journal-title":"Immunity"},{"issue":"4","key":"8234_CR30","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41423-025-01258-x","volume":"22","author":"H You","year":"2025","unstructured":"You H, Zhang X, Chen H, Liu C, Teng D, Han J, et al. \u03b3\u03b4 T-cell autoresponses to ectopic membrane proteins: a new type of pattern recognition. Cell Mol Immunol. 2025;22(4):356\u201370.","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"8234_CR31","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/mt.2014.104","volume":"22","author":"GM Siegers","year":"2014","unstructured":"Siegers GM, Lamb LS Jr. Cytotoxic and regulatory properties of circulating V\u03b41\u2009+\u2009\u03b3\u03b4 T cells: a new player on the cell therapy field? Mol therapy: J Am Soc Gene Therapy. 2014;22(8):1416\u201322.","journal-title":"Mol therapy: J Am Soc Gene Therapy"},{"issue":"3","key":"8234_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41573-019-0038-z","volume":"19","author":"Z Sebestyen","year":"2020","unstructured":"Sebestyen Z, Prinz I, D\u00e9chanet-Merville J, Silva-Santos B, Kuball J. Translating gammadelta (\u03b3\u03b4) T cells and their receptors into cancer cell therapies. Nat Rev Drug Discovery. 2020;19(3):169\u201384.","journal-title":"Nat Rev Drug Discovery"},{"issue":"12","key":"8234_CR33","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1182\/blood.2020005185","volume":"136","author":"D Stenger","year":"2020","unstructured":"Stenger D, Stief TA, Kaeuferle T, Willier S, Rataj F, Schober K, et al. Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR\/Cas9-mediated TCR knockout CAR. Blood. 2020;136(12):1407\u201318.","journal-title":"Blood"},{"issue":"5","key":"8234_CR34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1182\/bloodadvances.2017012823","volume":"2","author":"T Kamiya","year":"2018","unstructured":"Kamiya T, Wong D, Png YT, Campana D. A novel method to generate T-cell receptor-deficient chimeric antigen receptor T cells. Blood Adv. 2018;2(5):517\u201328.","journal-title":"Blood Adv"},{"issue":"8","key":"8234_CR35","doi-asserted-by":"publisher","first-page":"110858","DOI":"10.1016\/j.celrep.2022.110858","volume":"39","author":"JL McMurray","year":"2022","unstructured":"McMurray JL, von Borstel A, Taher TE, Syrimi E, Taylor GS, Sharif M, et al. Transcriptional profiling of human V\u03b41 T cells reveals a pathogen-driven adaptive differentiation program. Cell Rep. 2022;39(8):110858.","journal-title":"Cell Rep"},{"issue":"3","key":"8234_CR36","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s43018-023-00690-0","volume":"5","author":"D Davies","year":"2024","unstructured":"Davies D, Kamdar S, Woolf R, Zlatareva I, Iannitto ML, Morton C, et al. PD-1 defines a distinct, functional, tissue-adapted state in V\u03b41(+) T cells with implications for cancer immunotherapy. Nat cancer. 2024;5(3):420\u201332.","journal-title":"Nat cancer"},{"issue":"1","key":"8234_CR37","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41385-021-00447-x","volume":"15","author":"C Khairallah","year":"2022","unstructured":"Khairallah C, Bettke JA, Gorbatsevych O, Qiu Z, Zhang Y, Cho K, et al. A blend of broadly-reactive and pathogen-selected V\u03b34 V\u03b41 T cell receptors confer broad bacterial reactivity of resident memory \u03b3\u03b4 T cells. Mucosal Immunol. 2022;15(1):176\u201387.","journal-title":"Mucosal Immunol"},{"issue":"690","key":"8234_CR38","doi-asserted-by":"publisher","first-page":"eabk1900","DOI":"10.1126\/scitranslmed.abk1900","volume":"15","author":"D Meyran","year":"2023","unstructured":"Meyran D, Zhu JJ, Butler J, Tantalo D, MacDonald S, Nguyen TN, et al. T(STEM)-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models. Sci Transl Med. 2023;15(690):eabk1900.","journal-title":"Sci Transl Med"},{"issue":"11","key":"8234_CR39","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.immuni.2022.09.014","volume":"55","author":"D Denk","year":"2022","unstructured":"Denk D, Petrocelli V, Conche C, Drachsler M, Ziegler PK, Braun A, et al. Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy. Immunity. 2022;55(11):2059\u2013e738.","journal-title":"Immunity"},{"issue":"suppl6","key":"8234_CR40","first-page":"vi20","volume":"18","author":"C Brown","year":"2016","unstructured":"Brown C, Alizadeh D, Starr R, Weng L, Wagner J, Naranjo A, et al. ATIM-13. Phase i study of chimeric antigen receptor-engineered t cells targeting il13r\u03b12 for the treatment of glioblastoma. Neurooncology. 2016;18(suppl6):vi20\u2013vi.","journal-title":"Neurooncology"},{"key":"8234_CR41","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","volume":"22","author":"F Sallusto","year":"2004","unstructured":"Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004;22:745\u201363.","journal-title":"Annu Rev Immunol"},{"issue":"5357","key":"8234_CR42","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1126\/science.279.5357.1737","volume":"279","author":"V Groh","year":"1998","unstructured":"Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Sci (New York NY). 1998;279(5357):1737\u201340.","journal-title":"Sci (New York NY)"},{"issue":"12","key":"8234_CR43","doi-asserted-by":"publisher","first-page":"6879","DOI":"10.1073\/pnas.96.12.6879","volume":"96","author":"V Groh","year":"1999","unstructured":"Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci USA. 1999;96(12):6879\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"8234_CR44","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1182\/blood-2011-02-339135","volume":"118","author":"DV Correia","year":"2011","unstructured":"Correia DV, Fogli M, Hudspeth K, da Silva MG, Mavilio D, Silva-Santos B. Differentiation of human peripheral blood V\u03b41\u2009+\u2009T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells. Blood. 2011;118(4):992\u20131001.","journal-title":"Blood"},{"issue":"9","key":"8234_CR45","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41423-020-0504-x","volume":"17","author":"D Kabelitz","year":"2020","unstructured":"Kabelitz D, Serrano R, Kouakanou L, Peters C, Kalyan S. Cancer immunotherapy with \u03b3\u03b4 T cells: many paths ahead of us. Cell Mol Immunol. 2020;17(9):925\u201339.","journal-title":"Cell Mol Immunol"},{"issue":"15","key":"8234_CR46","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1182\/blood.2023022992","volume":"143","author":"S Mensurado","year":"2024","unstructured":"Mensurado S, Conde\u00e7o C, S\u00e1nchez-Mart\u00ednez D, Shirley S, Coelho RML, Tirado N, et al. CD155\/PVR determines acute myeloid leukemia targeting by Delta One T cells. Blood. 2024;143(15):1488\u201395.","journal-title":"Blood"},{"issue":"4","key":"8234_CR47","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano L, Jord\u0101o MJC, Joyce JA. Therapeutic Targeting of the Tumor Microenvironment. Cancer Discov. 2021;11(4):933\u201359.","journal-title":"Cancer Discov"},{"key":"8234_CR48","doi-asserted-by":"crossref","unstructured":"Cruz C, Barba I. Lactic acid in tumour biology. Metabolites. 2026;16(1).","DOI":"10.3390\/metabo16010075"},{"issue":"16","key":"8234_CR49","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.2174\/0929867043364711","volume":"11","author":"S Walenta","year":"2004","unstructured":"Walenta S, Schroeder T, Mueller-Klieser W. Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. Curr Med Chem. 2004;11(16):2195\u2013204.","journal-title":"Curr Med Chem"},{"issue":"3","key":"8234_CR50","first-page":"1471","volume":"19","author":"RN Wang","year":"2019","unstructured":"Wang RN, Wen Q, He WT, Yang JH, Zhou CY, Xiong WJ, et al. Optimized protocols for \u03b3\u03b4 T cell expansion and lentiviral transduction. Mol Med Rep. 2019;19(3):1471\u201380.","journal-title":"Mol Med Rep"},{"issue":"11","key":"8234_CR51","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.molmed.2025.05.014","volume":"31","author":"YR Li","year":"2025","unstructured":"Li YR, Zhu Y, Yang L. IL-15 in CAR engineering: striking an efficacy-safety balance. Trends Mol Med. 2025;31(11):977\u201381.","journal-title":"Trends Mol Med"},{"issue":"12","key":"8234_CR52","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1182\/blood-2008-12-189266","volume":"114","author":"C Berger","year":"2009","unstructured":"Berger C, Berger M, Hackman RC, Gough M, Elliott C, Jensen MC, et al. Safety and immunologic effects of IL-15 administration in nonhuman primates. Blood. 2009;114(12):2417\u201326.","journal-title":"Blood"},{"key":"8234_CR53","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-immunol-032713-120216","volume":"32","author":"YH Chien","year":"2014","unstructured":"Chien YH, Meyer C, Bonneville M. \u03b3\u03b4 T cells: first line of defense and beyond. Annu Rev Immunol. 2014;32:121\u201355.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"8234_CR54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41571-022-00704-3","volume":"20","author":"CL Flugel","year":"2023","unstructured":"Flugel CL, Majzner RG, Krenciute G, Dotti G, Riddell SR, Wagner DL, et al. Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours. Nat reviews Clin Oncol. 2023;20(1):49\u201362.","journal-title":"Nat reviews Clin Oncol"},{"issue":"1","key":"8234_CR55","doi-asserted-by":"publisher","first-page":"5224","DOI":"10.1038\/s41467-020-19094-0","volume":"11","author":"C Mark","year":"2020","unstructured":"Mark C, Czerwinski T, Roessner S, Mainka A, H\u00f6rsch F, Heublein L, et al. Cryopreservation impairs 3-D migration and cytotoxicity of natural killer cells. Nat Commun. 2020;11(1):5224.","journal-title":"Nat Commun"},{"issue":"9","key":"8234_CR56","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jcyt.2019.07.004","volume":"21","author":"R Li","year":"2019","unstructured":"Li R, Johnson R, Yu G, McKenna DH, Hubel A. Preservation of cell-based immunotherapies for clinical trials. Cytotherapy. 2019;21(9):943\u201357.","journal-title":"Cytotherapy"},{"key":"8234_CR57","doi-asserted-by":"publisher","first-page":"1202950","DOI":"10.3389\/fimmu.2023.1202950","volume":"14","author":"A Kent","year":"2023","unstructured":"Kent A, Crump LS, Davila E. Beyond \u03b1\u03b2 T cells: NK, iNKT, and \u03b3\u03b4T cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML. Front Immunol. 2023;14:1202950.","journal-title":"Front Immunol"},{"key":"8234_CR58","doi-asserted-by":"publisher","first-page":"1554541","DOI":"10.3389\/fimmu.2025.1554541","volume":"16","author":"L Wang","year":"2025","unstructured":"Wang L, Li J, Xuan Y, Zhang J, Wang X, Hu W, et al. Prospects for \u03b3\u03b4 T cells and chimeric antigen receptor \u03b3\u03b4 T cells in cancer immunotherapy. Front Immunol. 2025;16:1554541.","journal-title":"Front Immunol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08234-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08234-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08234-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:02:12Z","timestamp":1785114132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08234-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8234"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08234-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All human peripheral blood samples were obtained from voluntary donors, and the study was approved by the CAMS Institutional Review Board # SB2025014. Informed consent was obtained in compliance with the Declaration of Helsinki. No interventional experiments were performed on the donors. All animal procedures were approved by the CAMS Institutional Animal Care and Use Committee # ACUC-XMSB-2025-001 and were performed in accordance with the ARRIVE guidelines and the 3R principles.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors agree to submit the research article for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"960"}}